Abstract:Lipopolysaccharide (LPS), a gut-transmitted endotoxin from Gram-negative bacteria, causes inflammatory diseases leading to the loss of gut barrier integrity and has been identified as a major pathogenic stimulator in many dysfunctions. Hence, supplementation with probiotics is believed to be one of the most effective strategies for treating many inflammatory gut disorders. Although probiotics are known to have a variety of therapeutic characteristics and to play a beneficial role in host defense responses, the molecular mechanisms by which they achieve these beneficial effects are unknown due to species- and strain-specific behaviors. Therefore, in this study, the protective role of five indigenous lactic acid bacterial strains in ameliorating LPS-induced gut barrier impairment in the C57BL/6 mice model was elucidated. Lacticaseibacillus rhamnosus LAB3, Levilactobacillus brevis LAB20, and Lactiplantibacillus plantarum LAB31 were isolated from infant feces; Pediococcus acidilactici LAB8 from fermented food (Bekang); and Lactiplantibacillus plantarum LAB39 from beetroot. Intraperitoneal injection of LPS (10 mg/kg of body weight) increased the levels of lipocalin and serum markers TNF-α, IL-6, and IL-1β, and the overall disease activity index in the treated group. Furthermore, gene expression of NF-kB, IL-12, and Cox-2; mucin-producing genes Muc-2 and Muc-4; and intestinal alkaline phosphatase (IAP) was deleteriously altered in the ileum of LPS-treated mice. Furthermore, LPS also induced dysbiosis in gut microbiota where higher abundances of Klebsiella, Enterobacter, and Salmonella and decreased abundances of Lactobacillus, Bifidobacteria, Roseburia, and Akkermansia were observed. Western blotting results also suggested that LPS treatment causes the loss of gut barrier integrity relative to the pre-supplementation with LAB strains, which enhanced the expression of tight junction proteins and ameliorated the LPS-induced changes and inflammation. Taken together, the study suggested that LAB3 and LAB39 were more potent in ameliorating LPS-induced gut inflammation and dysbiosis.

Isolation of lactic acid bacteria capable of reducing environmental alkyl and fatty acid hydroperoxides, and the effect of their oral administration on oxidative-stressed nematodes and rats

Inhibition of Fe-induced Colon Oxidative Stress by Lactobacilli in Mice.

Effects of <i>Pediococcus pentosaceus</i> LI05 on immunity and metabolism in germ-free rats

Lactobacillus plantarum Exhibits Antioxidant and Cytoprotective Activities in Porcine Intestinal Epithelial Cells Exposed to Hydrogen Peroxide

Lactic Acid Bacteria Inhibit Mucosal Oxidative Stress of Colon in Dextran Sulfate Sodium-Induced Colitic Mice

Antioxidant Activity and Probiotic Properties of Lactic Acid Bacteria

Lactiplantibacillus Plantarum ZJ316 Alleviates the Oxidative Stress and Cellular Apoptosis Via Modulating Nrf2/HO-1 Signaling Pathway

Antioxidant and Anti-Inflammatory Effect and Probiotic Properties of Lactic Acid Bacteria Isolated from Canine and Feline Feces

Recent Perspective of <i>Lactobacillus</i> in Reducing Oxidative Stress to Prevent Disease

Lactobacillus Plantarum KLDS1.0386 with Antioxidant Capacity Ameliorates the Lipopolysaccharide-Induced Acute Liver Injury in Mice by NF-κB and Nrf2 Pathway

Reduction of hydrogen peroxide stress derived from fatty acid beta-oxidation improves fatty acid utilization in Escherichia coli

The antioxidative capacities of Lactobacillus and its potential mechanisms via chemical and cellular assessments

Exopolysaccharides Produced by Lactobacillus Rhamnosus GG Alleviate Hydrogen Peroxide-Induced Intestinal Oxidative Damage and Apoptosis Through the Keap1/Nrf2 and Bax/Bcl-2 Pathways in Vitro

Lactic Acid Bacterial Supplementation Ameliorated the Lipopolysaccharide-Induced Gut Inflammation and Dysbiosis in Mice

Recent Perspective of Lactobacillus in Reducing Oxidative Stress to Prevent Disease

Expression of Catalase in Lactobacillus Fermentum and Evaluation of Its Anti-Oxidative Properties in a Dextran Sodium Sulfate Induced Mouse Colitis Model

Supplementation of Lactobacillus Plantarum ATCC14917 Mitigates Non-Alcoholic Fatty Liver Disease in High-Fat-diet-fed Rats

Oral administration of the lactic acid bacterium Pediococcus acidilactici attenuates atherosclerosis in mice by inducing tolerogenic dendritic cells

Lactic Acid Bacteria Exhibit Similar Antioxidant Capacities Incaenorhabditis Elegans- Andcampylobacter Jejuni-Infected Mice

Probiotics Alleviate Oxidative Stress in H2O2-Exposed Hepatocytes and t-BHP-Induced C57BL/6 Mice